436 related articles for article (PubMed ID: 25402681)
21. Targeting the CD73-adenosine axis in immuno-oncology.
Allard D; Chrobak P; Allard B; Messaoudi N; Stagg J
Immunol Lett; 2019 Jan; 205():31-39. PubMed ID: 29758241
[TBL] [Abstract][Full Text] [Related]
22. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
[TBL] [Abstract][Full Text] [Related]
23. CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.
Mahamed DA; Toussaint LE; Bynoe MS
Infect Immun; 2015 Feb; 83(2):721-9. PubMed ID: 25452548
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of Clostridium difficile toxin-induced damage to epithelial barrier by ecto-5'-nucleotidase (CD73) and adenosine receptor signaling.
Schenck LP; Hirota SA; Hirota CL; Boasquevisque P; Tulk SE; Li Y; Wadhwani A; Doktorchik CT; Macnaughton WK; Beck PL; MacDonald JA
Neurogastroenterol Motil; 2013 Jun; 25(6):e441-53. PubMed ID: 23600886
[TBL] [Abstract][Full Text] [Related]
25. Intestinal Epithelial Ecto-5'-Nucleotidase (CD73) Regulates Intestinal Colonization and Infection by Nontyphoidal Salmonella.
Kao DJ; Saeedi BJ; Kitzenberg D; Burney KM; Dobrinskikh E; Battista KD; Vázquez-Torres A; Colgan SP; Kominsky DJ
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28717030
[TBL] [Abstract][Full Text] [Related]
26. Allergen-induced airway hyperresponsiveness is absent in ecto-5'-nucleotidase (CD73)-deficient mice.
Schreiber R; Castrop H; Kunzelmann K
Pflugers Arch; 2008 Nov; 457(2):431-40. PubMed ID: 18607626
[TBL] [Abstract][Full Text] [Related]
27. Lack of ecto-5'-nucleotidase (CD73) promotes arteriogenesis.
Böring YC; Flögel U; Jacoby C; Heil M; Schaper W; Schrader J
Cardiovasc Res; 2013 Jan; 97(1):88-96. PubMed ID: 22977005
[TBL] [Abstract][Full Text] [Related]
28. Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.
Petit-Jentreau L; Jouvion G; Charles P; Majlessi L; Gicquel B; Tailleux L
Infect Immun; 2015 Sep; 83(9):3666-74. PubMed ID: 26150535
[TBL] [Abstract][Full Text] [Related]
29. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
Yegutkin GG; Marttila-Ichihara F; Karikoski M; Niemelä J; Laurila JP; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2011 May; 41(5):1231-41. PubMed ID: 21469131
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice.
Buchheiser A; Ebner A; Burghoff S; Ding Z; Romio M; Viethen C; Lindecke A; Köhrer K; Fischer JW; Schrader J
Cardiovasc Res; 2011 Nov; 92(2):338-47. PubMed ID: 21955554
[TBL] [Abstract][Full Text] [Related]
31. Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice.
Burghoff S; Flögel U; Bongardt S; Burkart V; Sell H; Tucci S; Ikels K; Eberhard D; Kern M; Klöting N; Eckel J; Schrader J
Arch Physiol Biochem; 2013 May; 119(2):39-51. PubMed ID: 23398498
[TBL] [Abstract][Full Text] [Related]
32. Ecto-enzyme and signaling functions of lymphocyte CD73.
Resta R; Yamashita Y; Thompson LF
Immunol Rev; 1998 Feb; 161():95-109. PubMed ID: 9553767
[TBL] [Abstract][Full Text] [Related]
33. Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice.
Castrop H; Huang Y; Hashimoto S; Mizel D; Hansen P; Theilig F; Bachmann S; Deng C; Briggs J; Schnermann J
J Clin Invest; 2004 Sep; 114(5):634-42. PubMed ID: 15343381
[TBL] [Abstract][Full Text] [Related]
34. Impaired L-arginine metabolism marks endothelial dysfunction in CD73-deficient mice.
Mierzejewska P; Zabielska MA; Kutryb-Zajac B; Tomczyk M; Koszalka P; Smolenski RT; Slominska EM
Mol Cell Biochem; 2019 Aug; 458(1-2):133-142. PubMed ID: 31093850
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.
Figueiró F; de Oliveira CP; Bergamin LS; Rockenbach L; Mendes FB; Jandrey EH; Moritz CE; Pettenuzzo LF; Sévigny J; Guterres SS; Pohlmann AR; Battastini AM
Purinergic Signal; 2016 Jun; 12(2):303-12. PubMed ID: 26910734
[TBL] [Abstract][Full Text] [Related]
36. CD73 expression and fyn-dependent signaling on murine lymphocytes.
Yamashita Y; Hooker SW; Jiang H; Laurent AB; Resta R; Khare K; Coe A; Kincade PW; Thompson LF
Eur J Immunol; 1998 Oct; 28(10):2981-90. PubMed ID: 9808167
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.
De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685
[TBL] [Abstract][Full Text] [Related]
38. Ecto-5'-nucleotidase (CD73) is involved in chronic cerebral hypoperfusion-induced white matter lesions and cognitive impairment by regulating glial cell activation and pro-inflammatory cytokines.
Hou X; Liang X; Chen JF; Zheng J
Neuroscience; 2015 Jun; 297():118-26. PubMed ID: 25805696
[TBL] [Abstract][Full Text] [Related]
39. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice.
Montesinos MC; Takedachi M; Thompson LF; Wilder TF; Fernández P; Cronstein BN
Arthritis Rheum; 2007 May; 56(5):1440-5. PubMed ID: 17469101
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
